ReviewACS omega2026
Recent Advances in 3D-Printed Bioresorbable Vascular Stents: Toward Patient-Specific, Novel-Structured, Functional, and Smart Devices.
Review in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bioresorbable vascular stents (BVSs) offer a transformative therapeutic advantage over permanent metal stents by temporarily supporting the vessel and then fully degrading, thereby restoring natural vasomotion and eliminating long-term complications. However, their clinical translation has been hampered by inherent limitations of conventional manufacturing, including restricted material selection, inflexible design, and limited capability for functional integration. Three-dimensional (3D) printing emerges as a pivotal technology to address these challenges, enabling the fabrication of stents with customized architectures, complex structures, and integrated multifunctionality. This review systematically highlights the latest progress in 3D-printed BVSs, focusing on their evolution toward patient-specific, novel-structured, functional, and smart devices. It assesses advanced printing technologies, presents preclinical outcomes and preliminary clinical evidence of 3D-printed BVSs, discusses current challenges, and also provides some future research directions. By framing the current state of the art, this review aims to accelerate the development of next-generation vascular implants.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.